Andere talen Twist Bioscience Corporation

Aandelen

TWST

US90184D1000

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 18-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
28,36 ^USD	-0,74%		-13,22%	-23,06%

28/03	Twist Bioscience Corporation lanceert een Pangenome Spike-in Exome-panel om onderzoek naar diverse populaties te bevorderen	CI
12/03	Transcript : Twist Bioscience Corporation Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-12-2024 07:30 AM

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Twist Bioscience to Report Fiscal 2024 Second Quarter Financial Results on Thursday, May 2, 2024	18/04
Twist Bioscience Launches Pangenome Spike-in Exome Panel to Enable Advancement of Research for Diverse Populations	28/03
Twist Bioscience Corporation Launches Pangenome Spike-in Exome Panel to Enable Advancement of Research for Diverse Populations	28/03
Twist Bioscience Launches IVDR-compliant Precision Dx Products for Whole Exome Sequencing	05/03
Twist Bioscience Corporation Launches IVDR-Compliant Precision Dx Products for Whole Exome Sequencing	05/03
Twist Bioscience to Present at Upcoming Investor Conferences	22/02
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(4)	08/02
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)	07/02
Twist Bioscience Announces Partnership With Element Biosciences, Launches Liquid Biopsy Kit	06/02
Twist Bioscience and Element Biosciences Collaborate on Exome Sequencing Solutions for AVITI System	06/02
Twist Bioscience Corporation and Element Biosciences, Inc. Announce Collaboration to Develop Twist for Element, Exome 2.0 Plus Comprehensive Exome Spike-In Workflow for Element?s AVITI System	06/02
Twist Bioscience Launches cfDNA Library Preparation Kit for Liquid Biopsy Applications	06/02
Twist Bioscience Corporation Launches cfDNA Library Preparation Kit for Liquid Biopsy Applications	06/02
Twist Bioscience Unveils Differentiated Ultra High-Throughput Library Preparation Solution at AGBT	05/02
Twist Bioscience Corporation Unveils Differentiated Ultra High-Throughput Library Preparation Solution at AGBT	05/02
Twist Bioscience Reports Fiscal First Quarter 2024 Financial Results	05/02
Sector Update: Health Care Stocks Steady Premarket Friday	02/02
Twist Bioscience's Fiscal Q1 Net Loss Widens, Revenue Rises; Fiscal 2024 Revenue Guidance Lifted	02/02
Earnings Flash (TWST) TWIST BIOSCIENCE CORPORATION Reports Q1 Revenue $71.5M, vs. Street Est of $67.6M	02/02
Twist Bioscience: Fiscal Q1 Earnings Snapshot	02/02

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Twist Bioscience Corporation

Aandelen

TWST

US90184D1000

Andere talen

Filters